» Articles » PMID: 18948399

Deficiency of Angiotensin Type 2 Receptor Rescues Obesity but Not Hypertension Induced by Overexpression of Angiotensinogen in Adipose Tissue

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2008 Oct 25
PMID 18948399
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Increased angiotensinogen (AGT) production by white adipose tissue has been related to not only obesity but also hypertension. Several studies have highlighted the importance of the angiotensin II type 2 receptor (AT2) in the regulation of blood pressure and fat mass, but the relevance of this transporter in a physiopathological model of increased AGT production, as it occurs in obesity, has not yet been investigated. We used transgenic mice that display either a deletion of AT2 (AT2 KO), an overexpression of AGT (OVEX), or both compound mutants (KOVEX). Results demonstrated that adipocyte hypertrophy and increased lipogenic gene expression induced by adipose AGT overproduction was rescued by deletion of AT2. In line with AGT overexpression, KOVEX and OVEX mice have similar increased plasma AGT levels. However, KOVEX mice display a higher blood pressure than OVEX mice. In kidney, renin expression was clearly reduced in OVEX mice, and its expression was normalized in KOVEX mice. Taken together, we demonstrated that the loss of AT2 expression was sufficient to rescue obesity induced by adipose tissue AGT overexpression and confirmed the necessary role of AT2 for the onset of obesity in this model. Furthermore, despite a reduction of adipose mass in KOVEX, AT2 deficiency caused increased renin production, further worsening the hypertension caused by AGT overexpression.

Citing Articles

The Crowded Uterine Horn Mouse Model for Examining Postnatal Metabolic Consequences of Intrauterine Growth Restriction vs. Macrosomia in Siblings.

Taylor J, Coe B, Shioda T, Vom Saal F Metabolites. 2022; 12(2).

PMID: 35208177 PMC: 8880550. DOI: 10.3390/metabo12020102.


Synergizing Mouse and Human Studies to Understand the Heterogeneity of Obesity.

Gordon-Larsen P, French J, Moustaid-Moussa N, Voruganti V, Mayer-Davis E, Bizon C Adv Nutr. 2021; 12(5):2023-2034.

PMID: 33885739 PMC: 8483969. DOI: 10.1093/advances/nmab040.


Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Fatima N, Patel S, Hussain T Hypertension. 2021; 77(6):1845-1856.

PMID: 33840201 PMC: 8115429. DOI: 10.1161/HYPERTENSIONAHA.120.11941.


The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.

Ragino Y, Stakhneva E, Polonskaya Y, Kashtanova E Biomolecules. 2020; 10(3).

PMID: 32121175 PMC: 7175189. DOI: 10.3390/biom10030374.


Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis.

Tao X, Rong J, Lu H, Daugherty A, Shi P, Ke C J Lipid Res. 2019; 60(12):1983-1995.

PMID: 31604805 PMC: 6889717. DOI: 10.1194/jlr.M093252.